Evaluation of Anxiety Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Introduction:Mood disorders are frequently seen in the patients with chronic obstructive pulmonary disease (COPD). The literature lacks the frequency and effects of the anxiety disorder, which affects daily life and success of the treatment. In the present study, we evaluated the anxiety levels of p...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2022-08-01
|
| Series: | İstanbul Medical Journal |
| Subjects: | |
| Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/evaluation-of-anxiety-symptoms-in-patients-with-ch/52715
|
| Summary: | Introduction:Mood disorders are frequently seen in the patients with chronic obstructive pulmonary disease (COPD). The literature lacks the frequency and effects of the anxiety disorder, which affects daily life and success of the treatment. In the present study, we evaluated the anxiety levels of patients with COPD.Methods:The relatives diagnosed with COPD of the patients who applied for psychiatric examination as out-patients to our clinic were included in the study between January 2018 and December 2021. Eighty patients were randomly selected for the COPD group. The fourty-eight volunteer relatives of the patients were included in the control group. The two Spielberger State and Trait Anxiety Inventory subscores-state (STAI-S) and trait (STAI-T)- were used to examine anxiety levels of the patients with COPD and control groups.Results:There were 48 (60%) men and 32 (40%) women in the COPD group and 24 (50%) men, 24 (50%) women in the control group. The mean scores of Spielberger State Anxiety Inventory and Trait Anxiety Inventory were significantly higher in the COPD group when compared control group [STAI-S COPD group (n=80), mean score: 43.384, standard deviation (SD): 8.68 versus control group (n=48), mean score: 36,232, SD: 7.64; p<0.05] [STAI-T COPD group (n=80), mean score: 44,128, SD: 6.168 versus control group (n=48), mean score: 36,344, SD: 8.188; p<0.05, respectively].Conclusion:The anxiety symptoms in the patients with COPD should be considered by physicians and should be appropriately assessed when diagnosed with COPD for not only the effects on treatment compliance but also on mortality, disability and quality of life. We believe that psychiatric aid is important in patients with COPD, particularly in handling anxiety, so that the anxiety-dyspnea vicious cycle will be easier to break with insensitive behavior therapies. |
|---|---|
| ISSN: | 2619-9793 2148-094X |